The United Kingdom administers the first doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; an FDA review confirms the safety and efficacy of Pfizer's vaccine; Fauci advises holiday gatherings be limited to 10 or less people.
The first patients in the United Kingdom have received a Pfizer/BioNTech coronavirus disease 2019 (COVID-19) immunization as part of a new mass vaccination program, BBC News reports. Margaret Keenan, who turns 91 next week, received the first of 800,000 doses to be dispensed in the coming weeks. Vaccination hubs throughout the United Kingdom expect to vaccinate citizens 80 years and older and some health care staff soon, as up to 4 million more doses are expected to be administered by the end of the month. The United Kingdom is the first country in the world to begin distributing the vaccine, which was approved there last week.
A 53-page review published by the FDA confirmed that Pfizer and BioNTech’s COVID-19 vaccine meets the standard for emergency use authorization (EUA) in the United States. Reported by The Washington Post, the briefing document is the most detailed independent review yet of the data and confirms that the 2-shot regimen is 95% effective. Short-term adverse effects include sore arms, fatigue, headaches, muscle pain, and chills, which all typically resolve in 1 to 2 days. The review also concluded the vaccine can begin to protect individuals even after the first dose. An FDA advisory panel is slated to hear Pfizer’s application for its vaccine candidate this Thursday.
Anthony Fauci, MD, the nation’s top infectious disease expert, said Americans should limit holiday gatherings to 10 individuals or fewer to help stem the spread of COVID-19 surging across the nation, NPR reports. Fauci made the remarks during a COVID-19 briefing held by New York Governor Andrew Cuomo. Warning that holiday gatherings could emerge as major vectors of the disease, Fauci said he expects coronavirus cases to continue to rise nationwide into January. According to the Johns Hopkins Coronavirus Resource Center, the United States has reported just under 15 million cases of COVID-19 and around 284,000 deaths.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Support and Skepticism Emerge as Reactions to Robert F. Kennedy Jr’s HHS Nomination
November 15th 2024In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.
Read More